Puddy,
Are you based in OZ or the US?
I'm a long -time shareholder and a big fan of the product. I believe that in the medium term, we will do well out of this stock. But I think that even if they achieve their targets for the year, the cash situation will be too tight to not raise additional funding. I would hope that they could get a small bank line of credit, but fear that a capital raise is more likely which will of course put downward pressure on the share price.
The first quarter 4C will be very telling.
- Forums
- ASX - By Stock
- NXS
- Ann: Preliminary results of further XPERIENCE studies released
Ann: Preliminary results of further XPERIENCE studies released, page-5
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $55.51M |
Open | High | Low | Value | Volume |
19.0¢ | 19.0¢ | 19.0¢ | $4.762K | 25.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 87847 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 12222 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 87847 | 0.185 |
5 | 125794 | 0.180 |
2 | 17800 | 0.175 |
2 | 21000 | 0.170 |
1 | 31250 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 12222 | 4 |
0.205 | 7298 | 1 |
0.210 | 300 | 1 |
0.220 | 88792 | 2 |
0.225 | 4444 | 1 |
Last trade - 12.30pm 24/09/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online